How to Get Oral Micronized Progesterone in Washington

What Is Oral Micronized Progesterone and Why Does It Require a Prescription?

Oral micronized progesterone is bioidentical progesterone ground into microscopic particles, suspended in peanut oil, and sealed in a gelatin capsule to improve gastrointestinal absorption. The FDA approved Prometrium in 1998 for endometrial protection in postmenopausal women receiving estrogen therapy and for secondary amenorrhea. FDA Prometrium label Because progesterone acts on uterine tissue and carries hormonal risk profiles that vary by individual health history, the FDA classifies it as a Schedule-free but prescription-only drug.

Why Bioidentical Progesterone Differs From Synthetic Progestins

Synthetic progestins such as medroxyprogesterone acetate (MPA) bind progesterone receptors but also activate androgen and glucocorticoid receptors. That off-target activity drove much of the cardiovascular signal seen in the Women's Health Initiative. Oral micronized progesterone is structurally identical to endogenous progesterone and carries a more favorable receptor-selectivity profile. The PEPI Trial (JAMA 1995, N=875) found that women on conjugated equine estrogen plus micronized progesterone preserved HDL cholesterol significantly better than women on conjugated equine estrogen plus MPA (mean HDL increase 1.6 mg/dL vs. 0.0 mg/dL, P<0.001).

Standard Doses Used in Washington Prescriptions

Washington clinicians typically prescribe one of two regimens approved in the Prometrium label:

• Continuous combined HRT: 100 mg orally at bedtime every night alongside daily estrogen.
• Cyclic HRT: 200 mg orally at bedtime for days 1 through 12 of a 28-day calendar cycle.

The bedtime timing matters. Progesterone produces a mild sedating effect through GABA-A receptor modulation, and evening dosing converts that side effect into a sleep benefit for many patients. Bhatt DK et al., Menopause 2022

Who Can Prescribe Oral Micronized Progesterone in Washington?

Any Washington-licensed prescriber with authority to manage hormonal conditions may write this prescription. Washington State does not restrict hormone therapy prescribing to a single specialty.

Prescribers Authorized Under Washington Law

• MDs and DOs holding a valid Washington medical license.
• Nurse practitioners (ARNPs) operating under Washington's full practice authority statute (RCW 18.79.340), which allows independent prescribing without physician oversight.
• Physician assistants (PAs) prescribing in collaboration with a supervising physician per RCW 18.57A.

Washington is one of 27 states granting ARNPs full practice authority. AANP State Practice Environment Map, 2024 That means an NP-staffed telehealth platform can legally initiate progesterone therapy without routing the prescription through an MD co-signer.

Telehealth Prescribing: Fully Permitted in Washington

Washington's telehealth parity law (RCW 70.41.020) requires commercial insurers to cover telehealth services at the same rate as in-person visits. Washington State Legislature, RCW 70.41.020 A telehealth prescriber may conduct the intake evaluation by synchronous video, establish a valid patient-provider relationship, and transmit a progesterone prescription electronically to a Washington-licensed pharmacy. No in-person visit is legally required before the prescription is issued.

Labs Required Before Starting Oral Micronized Progesterone in Washington

Most Washington clinicians order a baseline panel before initiating or adjusting progesterone. The exact panel varies by practice, but the following tests appear in standard HRT protocols endorsed by the Menopause Society (formerly NAMS). Menopause Society HRT Position Statement, 2023

Core Hormone Panel

| Test | Purpose | |---|---| | Serum estradiol (E2) | Confirm menopausal status; guide estrogen dose | | FSH | Distinguish perimenopause from menopause | | LH | Supporting hormonal context | | Total and free testosterone | Rule out androgen excess; baseline for HRT monitoring | | SHBG | Interpret free-hormone fractions accurately | | TSH | Thyroid dysfunction mimics perimenopause symptoms |

Metabolic Safety Panel

| Test | Purpose | |---|---| | CBC | Screen for anemia before initiating therapy | | CMP (BMP + LFTs) | Hepatic metabolism of progesterone is significant; liver baseline matters | | Fasting lipid panel | Cardiovascular risk stratification before adding any hormone | | Fasting glucose or HbA1c | Progesterone may modestly affect insulin sensitivity at high doses |

Progesterone is metabolized hepatically via CYP3A4. NIH Drug Interaction Data, CYP3A4 substrates Any patient on CYP3A4 inducers (rifampin, carbamazepine, phenytoin) or inhibitors (ketoconazole, clarithromycin) needs a medication reconciliation before dosing is finalized.

Imaging and Gynecologic Screening

Washington clinicians also typically require:

• A current pelvic exam or gynecologic history within 12 months.
• Pap smear within USPSTF-recommended intervals (every 3 years for ages 21 to 65, or every 5 years with co-test). USPSTF Cervical Cancer Screening Recommendation, 2018
• Mammogram within 1 to 2 years for patients over 40, per ACR guidelines. American College of Radiology Breast Density Guidelines, 2023

Telehealth providers may accept documentation of recent labs and imaging from a prior provider rather than requiring repeat testing, which shortens the time to a filled prescription.

Telehealth Providers in Washington Prescribing Oral Micronized Progesterone

Several telehealth platforms are licensed to prescribe hormone therapy in Washington. They differ in wait times, pricing models, and whether they use a cash-pay or insurance-billing structure.

What to Look For in a Washington Telehealth HRT Provider

1. Washington state medical or ARNP license held by the treating clinician. Verify at the Washington State Department of Health license lookup portal before booking. WA DOH License Lookup
2. Synchronous video capability. Washington telehealth parity law covers synchronous audio-video visits; some insurers do not cover audio-only for new patient hormone evaluations.
3. Electronic prescribing to Washington pharmacies. Confirm the platform can send prescriptions to chain pharmacies (Walgreens, Rite Aid, Costco Pharmacy) or your preferred independent pharmacy.
4. Secure lab-order integration. The best platforms send lab orders to Quest Diagnostics or LabCorp locations in Washington and review results before the prescription is written.

Typical Telehealth Timeline for Washington Patients

| Step | Estimated Time | |---|---| | Account creation and intake form | 15 to 30 minutes | | Lab draw at local Quest/LabCorp | Same day to 48 hours | | Lab results returned to provider | 24 to 72 hours | | Clinician review and Rx transmission | Same day as results | | Pharmacy fill and pickup or shipping | 1 to 3 days | | Total: consult to medication in hand | 3 to 7 days |

Where to Fill an Oral Micronized Progesterone Prescription in Washington

Washington patients have three categories of pharmacy to choose from.

Retail Chain Pharmacies

CVS, Walgreens, Rite Aid, Costco Pharmacy, and Fred Meyer Pharmacy all stock Prometrium and its generics. Generic oral micronized progesterone 100 mg (30 capsules) costs roughly $40, $65 without insurance at major Washington chains as of 2025, based on GoodRx pricing aggregated across Seattle, Spokane, and Tacoma zip codes. Prometrium brand-name costs $180, $220 for the same quantity. Using a GoodRx or Optum Perks coupon at a participating chain pharmacy typically brings the generic price below $35.

503A Compounding Pharmacies in Washington

Washington-licensed 503A pharmacies may prepare custom-dose compounded progesterone capsules when a commercially available product does not meet a patient's documented clinical need. Common reasons include:

• Peanut allergy (Prometrium uses peanut oil as a carrier; compounded capsules can use sunflower oil or olive oil).
• Non-standard doses (e.g., 50 mg for perimenopausal sleep support, or 150 mg for a specific endometrial protection protocol).

503A pharmacies dispense compounded preparations on a patient-specific prescription basis. The Washington State Pharmacy Board requires these pharmacies to hold a valid Washington compounding pharmacy license. Washington State Pharmacy Quality Assurance Commission Compounded progesterone is not FDA-approved as a finished product, so your prescriber must document clinical necessity.

Mail-Order and Specialty Pharmacies

Several mail-order pharmacies licensed in Washington ship progesterone directly to patients. Express Scripts, Optum Rx, and Rite Aid's mail-order division all fulfill progesterone prescriptions for Washington-state plan members. Shipping takes 2 to 5 business days standard or 1 to 2 days overnight.

Insurance Coverage and Prior Authorization in Washington

Commercial Insurance Coverage

Most commercial plans in Washington cover Prometrium and generic progesterone under their formulary for the FDA-approved indication (endometrial protection with concurrent estrogen in women with an intact uterus). Coverage tiers vary: generics land on Tier 1 or Tier 2 in most Washington Exchange plans, while Prometrium brand typically sits on Tier 3.

Washington's insurance commissioner requires plans to follow the ACA's women's preventive services mandate. HHS Women's Preventive Services Guidelines, 2024 That mandate covers contraceptive hormones but does not automatically extend to menopausal HRT. Patients using progesterone for HRT rather than contraception should verify their specific plan formulary.

Washington Medicaid (Apple Health) Coverage

Apple Health (Washington Medicaid) covers oral micronized progesterone for endometrial protection on HRT with prior authorization. The prior authorization (PA) process under Apple Health requires:

1. A diagnosis code (ICD-10 N95.1 for menopausal and female climacteric states, or N91.x for amenorrhea).
2. Documentation that the patient is concurrently using estrogen therapy and has an intact uterus.
3. A prescriber attestation that the drug is being used for an FDA-approved indication or a recognized off-label use supported by peer-reviewed evidence.

The Menopause Society's 2022 Hormone Therapy Position Statement is commonly cited by Washington prescribers to support PA submissions. Menopause Society 2022 HT Position Statement That document concludes: "For women who have a uterus, a progestogen is needed to protect the endometrium" and specifically identifies oral micronized progesterone as a preferred progestogen option.

Prior Authorization Documentation Checklist

• Completed PA request form from the insurer.
• Office notes documenting menopausal diagnosis and intact uterus.
• Current medication list confirming concurrent estrogen use.
• Lab values supporting hormonal status (FSH, E2).
• Reference to supporting guideline (Menopause Society 2022 preferred; ACOG Practice Bulletin No. 141 also accepted). ACOG Practice Bulletin No. 141

PA decisions under Washington Medicaid typically take 2 to 5 business days for standard review or 24 hours for urgent clinical review.

Transferring an Existing Oral Micronized Progesterone Prescription to Washington

Patients relocating to Washington or switching pharmacies can transfer an existing oral micronized progesterone prescription under Washington pharmacy law, subject to the following rules.

Transfer Rules for Schedule-Free Prescriptions

Progesterone is not a controlled substance. Washington pharmacy regulations therefore allow an unlimited number of transfers for non-controlled prescriptions, as long as remaining refills exist on the original prescription. Washington Administrative Code 246-869-100 The receiving Washington pharmacy calls the originating pharmacy, records the prescriber DEA number (if applicable) and license number, and enters the remaining refill count.

What You Need to Initiate a Transfer

• Name and phone number of the originating pharmacy.
• Your date of birth and the drug name and strength.
• Your Washington delivery address (for mail-order transfers).

Telehealth patients who received an electronic prescription from an out-of-state provider face a different situation. Out-of-state prescribers must hold a Washington telemedicine license or a compact privilege under the Interstate Medical Licensure Compact (IMLC) to continue prescribing to a Washington patient. Interstate Medical Licensure Compact, 2024 participant states If your current telehealth provider lacks Washington licensure, you will need a new consult with a Washington-licensed prescriber.

Safety Considerations and Contraindications

Oral micronized progesterone is generally well tolerated, but prescribers in Washington will screen for the following before issuing a prescription.

Absolute Contraindications

• Known or suspected pregnancy. FDA Prometrium label, Section 4
• Undiagnosed abnormal genital bleeding.
• Known hypersensitivity to progesterone or peanut oil (the Prometrium vehicle).
• Active thromboembolic disorder or a history of hormone-associated thromboembolism.
• Known or suspected breast cancer or other hormone-sensitive malignancy.
• Active or recent (within 12 months) arterial thromboembolic disease (stroke, MI).

Common Side Effects Reported in Trials

The Prometrium prescribing information reports somnolence in up to 45% of women receiving 300 mg doses in clinical trials, dropping to roughly 15% at the 100 mg dose used for continuous combined HRT. FDA Prometrium label, Section 6 Other common effects include dizziness (9%), headache (16%), and breast tenderness (16%).

A 2020 Cochrane review of progesterone for perimenopausal symptoms (including 12 randomized controlled trials) found that progesterone improved sleep onset latency by a mean of 9.8 minutes compared to placebo, with a pooled effect size of 0.48. Cochrane Library: Progesterone for perimenopausal symptoms, 2020

Monitoring After Starting Therapy

Washington clinicians typically schedule a follow-up at 6 to 8 weeks after initiation to review:

• Symptom response (sleep, vasomotor symptoms, mood).
• Breakthrough bleeding (common in the first 1 to 3 months on continuous regimens).
• Repeat lipid panel at 3 months if baseline was abnormal.
• Repeat E2 and progesterone levels at the 3-month visit if dosing changes are anticipated.

The Endocrine Society's Clinical Practice Guideline on menopause recommends reassessing HRT need annually and using the lowest effective dose for the shortest duration consistent with treatment goals. Endocrine Society Menopause Clinical Practice Guideline, 2015

Clinical Evidence Supporting Oral Micronized Progesterone

PEPI Trial Findings

The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial enrolled 875 postmenopausal women and randomized them to five arms across 3 years. PEPI Trial, JAMA 1995 The micronized progesterone arm (conjugated equine estrogen 0.625 mg plus micronized progesterone 200 mg cyclic) produced the best HDL outcome of any active treatment group, with a mean HDL increase of 1.6 mg/dL versus a decrease of 1.2 mg/dL in the MPA arm. Endometrial hyperplasia rates in the progesterone arm were statistically indistinguishable from placebo, confirming adequate endometrial protection.

E3N Cohort and Breast Cancer Risk

The French E3N cohort study (N=80,377 postmenopausal women followed for a mean 8.1 years) found that transdermal estrogen combined with oral micronized progesterone was not associated with an increased breast cancer risk (relative risk 1.00, 95% CI 0.83 to 1.22), in contrast to transdermal estrogen combined with synthetic progestins (relative risk 1.69, 95% CI 1.50 to 1.91). Fournier A et al., Breast Cancer Research and Treatment, 2008 This finding drives many Washington clinicians to prefer micronized progesterone over norethindrone acetate or MPA in HRT combinations.

KEEPS Trial: Cognitive and Cardiovascular Signals

The Kronos Early Estrogen Prevention Study (KEEPS, N=727, mean age 52.6 years at enrollment, 4-year follow-up) compared two HRT regimens in recently menopausal women and found no significant difference in carotid intima-media thickness progression between either HRT arm and placebo, but did observe mood and sleep benefits in women receiving oral progesterone. KEEPS Trial, Annals of Internal Medicine 2014 The trial used oral micronized progesterone 200 mg for 12 days per month in the oral estrogen arm.

Step-by-Step: Getting Your Prescription in Washington

The path from decision to dispensed prescription breaks into six steps.

1. Choose your prescriber type. In-person OB-GYN or primary care if you prefer face-to-face evaluation; Washington-licensed telehealth platform if you want faster access or live in a rural area with limited specialist availability.

2. Order labs before or at your first visit. Most telehealth platforms send lab orders electronically to your nearest Quest or LabCorp. In-person clinics draw labs on-site. Turnaround is 24 to 72 hours for standard panels.

3. Complete your intake visit. A synchronous video visit (30 to 45 minutes) or in-office appointment covers your symptom history, menstrual or menopausal history, cardiovascular risk factors, and medication review. Bring your imaging reports (mammogram, pelvic exam) if available.

4. Receive and verify your prescription. The clinician sends an e-prescription to your preferred Washington pharmacy. Verify the drug name (progesterone, micronized), strength (100 mg or 200 mg), quantity (30 or 90 capsules), and refills.

5. Fill at your Washington pharmacy or 503A compounder. Generic progesterone 100 mg costs roughly $35, $65 at retail Washington pharmacies with a discount card. Insurance copays range from $0 (Tier 1 generic) to $45 (Tier 3 brand) depending on your plan.

6. Schedule your 6-to-8-week follow-up. Telehealth platforms typically offer asynchronous messaging for minor questions between visits; a formal video follow-up at 6 to 8 weeks confirms therapeutic response and addresses any side effects.